Chengdu Easton Biopharmaceuticals Co.,Ltd.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference 38db65d197
Drug names57First applicant · distinct drug namesAcceptance records108First applicant · distinct acceptance numbersUnder-review numbers12First applicant · current under-review listCo-applicant records28Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
108 acceptance records as first applicant, grouped into 57 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
No verified English name 3 records · Latest accepted 2026/09/23
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2601195 | New drug | 2026/09/23 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CXHS2400088 | New drug | 2024/08/31 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CXHL2200533 | New drug | 2022/07/26 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Nalbuphine Hydrochloride Injection 6 records · Latest accepted 2026/09/22
Supplement · 4Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601794 | Supplement | 2026/09/22 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHB2601793 | Supplement | 2026/09/22 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHB2401685 | Supplement | 2024/10/19 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHB2401684 | Supplement | 2024/10/19 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2200043 | Generic | 2022/01/11 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2200042 | Generic | 2022/01/11 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/09/08
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602242 | Generic | 2026/09/08 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2602241 | Generic | 2026/09/08 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2602240 | Generic | 2026/09/08 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Axitinib Tablets 2 records · Latest accepted 2026/07/06
Supplement · 1Generic · 1
No verified English name 1 records · Latest accepted 2026/06/16
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600719 | New drug | 2026/06/16 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Landiolol Hydrochloride for Injection 3 records · Latest accepted 2026/06/16
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601421 | Generic | 2026/06/16 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHL2400154 | Generic | 2024/07/23 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2303488 | Generic | 2023/12/15 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Nafamostat Mesilate for Injection 2 records · Latest accepted 2026/06/15
Generic · 2
Morphine Sulfate and Naltrexone Hydrochloride Extended-release Capsules 5 records · Latest accepted 2026/05/14
New drug · 2Generic · 2Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600072 | New drug | 2026/05/14 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CXHS2600071 | New drug | 2026/05/14 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2404077 | Generic | 2024/11/27 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2404075 | Generic | 2024/11/27 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CXHB2200140 | Supplement | 2022/08/30 | Chengdu Easton Biopharmaceuticals Co.,Ltd.; Sichuan Yang Guang Run He Pharma Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/10/17
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2501137 | New drug | 2025/10/17 | Chengdu Easton Biopharmaceuticals Co.,Ltd.; Zhongguo Ke College Shanghai Drug Research Institute romanized; Zhong Ke Zhong Shan Drug Innovation Research Institute romanized | CDE ↗ |
| CXHL2501136 | New drug | 2025/10/17 | Chengdu Easton Biopharmaceuticals Co.,Ltd.; Zhongguo Ke College Shanghai Drug Research Institute romanized; Zhong Ke Zhong Shan Drug Innovation Research Institute romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/07/17
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2500600 | New drug | 2025/07/17 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/07/10
New drug · 2
No verified English name 1 records · Latest accepted 2025/07/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502450 | Generic | 2025/07/09 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Vitamin K1 Injection 2 records · Latest accepted 2025/06/06
Generic · 2
No verified English name 1 records · Latest accepted 2025/03/28
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500333 | New drug | 2025/03/28 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Tenofovir alafenamide Fumarate Tablets 1 records · Latest accepted 2025/02/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500402 | Supplement | 2025/02/27 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/12/31
New drug · 2
Mirogabalin Besilate Tablets 3 records · Latest accepted 2024/12/27
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404571 | Generic | 2024/12/27 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2404570 | Generic | 2024/12/27 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2404569 | Generic | 2024/12/27 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/10/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403647 | Generic | 2024/10/26 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Eptazocine Hydrobromide Injection 1 records · Latest accepted 2024/09/26
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401010 | New drug | 2024/09/26 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Brexpiprazole Tablets 6 records · Latest accepted 2024/07/18
Generic · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402230 | Generic | 2024/07/18 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2402229 | Generic | 2024/07/18 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2402228 | Generic | 2024/07/18 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2101163 | Generic | 2021/05/17 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2101162 | Generic | 2021/05/17 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2101161 | Generic | 2021/05/17 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Arotinolol Hydrochloride Tablets 2 records · Latest accepted 2024/07/09
Generic · 2
Ibuprofen Injection 3 records · Latest accepted 2024/06/14
Supplement · 2Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400821 | Supplement | 2024/06/14 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHB2400820 | Supplement | 2024/06/14 | Chengdu Easton Biopharmaceuticals Co.,Ltd.; Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200644 | Generic | 2022/04/29 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Nalfurafine Hydrochloride OD Tablets 1 records · Latest accepted 2024/06/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401764 | Generic | 2024/06/12 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Phenylephrine Hydrochloride Injection 2 records · Latest accepted 2024/05/29
Supplement · 1Generic · 1
Perampanel Tablets 2 records · Latest accepted 2024/05/08
Generic · 2
No verified English name 1 records · Latest accepted 2024/03/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400825 | Generic | 2024/03/14 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2024/01/27
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450069 | Supplement | 2024/01/27 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHB2101795 | Supplement | 2021/09/13 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHB2101794 | Supplement | 2021/09/13 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/01/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450042 | Supplement | 2024/01/16 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Oxazepam Tablets 1 records · Latest accepted 2024/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400144 | Generic | 2024/01/10 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Apalutamide Tablets 1 records · Latest accepted 2024/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400138 | Generic | 2024/01/10 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/12/26
Supplement · 2
Diprophylline Injection 1 records · Latest accepted 2023/12/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303495 | Generic | 2023/12/16 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2023/10/26
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2301170 | New drug | 2023/10/26 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CXHL2301169 | New drug | 2023/10/26 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CXHL2301168 | New drug | 2023/10/26 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Vecuronium Bromide For Injection 1 records · Latest accepted 2023/10/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302672 | Generic | 2023/10/10 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/10/09
New drug · 2
Remimazolam Besylate For Injection 1 records · Latest accepted 2023/09/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302375 | Generic | 2023/09/05 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Esomeprazole Magnesium for Delayed-release Oral Suspension 4 records · Latest accepted 2023/08/26
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301913 | Supplement | 2023/08/26 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHB2301912 | Supplement | 2023/08/26 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2102094 | Generic | 2021/11/29 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHS2102093 | Generic | 2021/11/29 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Bumetanide Injection 1 records · Latest accepted 2023/06/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301586 | Generic | 2023/06/10 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Ruxolitinib Phosphate Tablets 1 records · Latest accepted 2023/05/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301296 | Generic | 2023/05/12 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Beraprost Sodium Tablets 2 records · Latest accepted 2023/03/07
Generic · 2
Dacomitinib Tablets 2 records · Latest accepted 2023/02/11
Generic · 2
No verified English name 2 records · Latest accepted 2022/11/04
Supplement · 2
Compound Glycyrrhizin Tablets 1 records · Latest accepted 2022/09/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201423 | Generic | 2022/09/02 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Butorphanol Tartrate Injection 2 records · Latest accepted 2022/07/19
Generic · 2
Dobutamine Hydrochloride Injection 1 records · Latest accepted 2022/07/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201088 | Generic | 2022/07/18 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Dopamine Hydrochloride Injection 2 records · Latest accepted 2022/06/13
Generic · 2
Enalapril Maleate Oral Solution 1 records · Latest accepted 2022/04/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200518 | Generic | 2022/04/01 | Chengdu Easton Biopharmaceuticals Co.,Ltd.; Huayi Pharmaceuticals (Anhui) Co., Ltd. | CDE ↗ |
Lacosamide Oral Solution 1 records · Latest accepted 2022/03/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200387 | Generic | 2022/03/07 | Chengdu Easton Biopharmaceuticals Co.,Ltd.; Huayi Pharmaceuticals (Anhui) Co., Ltd. | CDE ↗ |
Aripiprazole Oral Solution 2 records · Latest accepted 2022/01/24
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200104 | Generic | 2022/01/24 | Chengdu Easton Biopharmaceuticals Co.,Ltd.; NORTH CHINA PHARMACEUTICAL COMPANY.LTD | CDE ↗ |
| CYHS2200103 | Generic | 2022/01/24 | Chengdu Easton Biopharmaceuticals Co.,Ltd.; NORTH CHINA PHARMACEUTICAL COMPANY.LTD | CDE ↗ |
Neostigmine Methylsulfate Injection 2 records · Latest accepted 2022/01/17
Generic · 2
Nicorandil for Injection 1 records · Latest accepted 2021/12/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102156 | Generic | 2021/12/08 | Chengdu Easton Biopharmaceuticals Co.,Ltd.; Shanxi Pu De Pharma Co., Ltd. romanized | CDE ↗ |
Dabigatran Etexilate Capsules 2 records · Latest accepted 2021/08/24
Supplement · 2
Nicardipine Hydrochloride Injection 1 records · Latest accepted 2021/06/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101230 | Generic | 2021/06/01 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Bisoprolol Fumarate Tablets 1 records · Latest accepted 2021/04/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101154 | Supplement | 2021/04/23 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Palonosetron Hydrochloride Injection 1 records · Latest accepted 2021/03/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100258 | Generic | 2021/03/05 | Chengdu Easton Biopharmaceuticals Co.,Ltd.; Guangdong Sunho Pharmaceutical Co., Ltd. | CDE ↗ |
Capecitabine Tablets 1 records · Latest accepted 2021/02/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2100231 | Supplement | 2021/02/09 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Sodium Valproate Concentrated Solution for Injection 2 records · Latest accepted 2021/01/30
Generic · 2
Changes in the last 90 days
6 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 6 applications
- 2026/09/23Accepted
No verified English name
CXHL2601195
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗ - 2026/09/22Accepted
Nalbuphine Hydrochloride Injection
CYHB2601794
Fact date: 2026/09/22 · Site observation date: 2026/10/22
View source ↗ - 2026/09/22Accepted
Nalbuphine Hydrochloride Injection
CYHB2601793
Fact date: 2026/09/22 · Site observation date: 2026/10/22
View source ↗ - 2026/09/08Accepted
No verified English name
CYHS2602242
Fact date: 2026/09/08 · Site observation date: 2026/10/22
View source ↗ - 2026/09/08Accepted
No verified English name
CYHS2602241
Fact date: 2026/09/08 · Site observation date: 2026/10/22
View source ↗ - 2026/09/08Accepted
No verified English name
CYHS2602240
Fact date: 2026/09/08 · Site observation date: 2026/10/22
View source ↗
Under review
12 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | CXHL2601195 | New drug | 2026/09/23 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Nalbuphine Hydrochloride Injection | CYHB2601794 | Supplement | 2026/09/22 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Nalbuphine Hydrochloride Injection | CYHB2601793 | Supplement | 2026/09/22 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | CYHS2602242 | Generic | 2026/09/08 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | CYHS2602241 | Generic | 2026/09/08 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | CYHS2602240 | Generic | 2026/09/08 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Axitinib Tablets | CYHB2601267 | Supplement | 2026/07/06 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Landiolol Hydrochloride for Injection | CYHS2601421 | Generic | 2026/06/16 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Nafamostat Mesilate for Injection | CYHS2601408 | Generic | 2026/06/15 | Chengdu Easton Biopharmaceuticals Co.,Ltd.; Chengdu Tong De Pharma Co., Ltd. romanized | CDE ↗ |
| Morphine Sulfate and Naltrexone Hydrochloride Extended-release Capsules | CXHS2600072 | New drug | 2026/05/14 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Morphine Sulfate and Naltrexone Hydrochloride Extended-release Capsules | CXHS2600071 | New drug | 2026/05/14 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | CYHS2502450 | Generic | 2025/07/09 | Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
Catalogue holder records
70 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Vitamin K1 Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20266188 | 2026/09/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Remimazolam Besylate For Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20265199 | 2026/07/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mirogabalin Besilate Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20264691 | 2026/06/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vitamin K1 Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20264352 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brexpiprazole Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20256115 | 2025/12/03 | Not stated by source | CDE ↗ |
| Brexpiprazole Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20256114 | 2025/12/03 | Not stated by source | CDE ↗ |
| Brexpiprazole Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20256116 | 2025/12/03 | Not stated by source | CDE ↗ |
| Arotinolol Hydrochloride Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20255424 | 2025/09/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Perampanel Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20255314 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Perampanel Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20255313 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nalfurafine Hydrochloride OD Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20255225 | 2025/08/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Phenylephrine Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20258164 | 2025/08/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20254836 | 2025/07/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Axitinib Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20254331 | 2025/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oxazepam Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20254336 | 2025/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Diprophylline Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20253579 | 2025/03/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bumetanide Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20253233 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vecuronium Bromide For Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20253159 | 2025/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ruxolitinib Phosphate Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20249398 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Compound Glycyrrhizin Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20244585 | 2024/07/30 | Not stated by source | CDE ↗ |
| No verified English name | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20094031 | 2024/07/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Beraprost Sodium Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20243696 | 2024/05/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Butorphanol Tartrate Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20243407 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Butorphanol Tartrate Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20243406 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nicorandil for Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Shanxi Pu De Pharma Co., Ltd. romanized | 国药准字H20243345 | 2024/03/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nalbuphine Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20243242 | 2024/02/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nalbuphine Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20243241 | 2024/02/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dobutamine Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20234629 | 2023/12/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dopamine Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20234373 | 2023/10/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dopamine Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20234372 | 2023/10/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Neostigmine Methylsulfate Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20233878 | 2023/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Neostigmine Methylsulfate Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20233879 | 2023/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nicardipine Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20223768 | 2022/10/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sugammadex Sodium Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20223382 | 2022/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vigabatrin Powder for Oral Solution | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20223287 | 2022/05/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Phenylephrine Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20223286 | 2022/05/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Valproate Concentrated Solution for Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20223266 | 2022/04/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Valproate Concentrated Solution for Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20223265 | 2022/04/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palonosetron Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Guangdong Sunho Pharmaceutical Co., Ltd. | 国药准字H20223210 | 2022/04/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Naloxone Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20053316 | 2021/08/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Naloxone Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20053314 | 2021/08/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Naloxone Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20053315 | 2021/08/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Paricalcitol Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203147 | 2021/07/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Paricalcitol Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203146 | 2021/07/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olanzapine Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20213319 | 2021/04/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dabigatran Etexilate Capsules | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20213281 | 2021/04/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dabigatran Etexilate Capsules | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20213282 | 2021/04/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tenofovir alafenamide Fumarate Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20213274 | 2021/04/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Ibandronate Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20123095 | 2021/03/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sodium Ibandronate Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20123094 | 2021/03/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sodium Ibandronate Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20123090 | 2021/03/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Caffeine Citrate Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20184023 | 2021/02/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Caffeine Citrate Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20163401 | 2021/02/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Fasudil Hydrochloride Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20113249 | 2021/01/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Parecoxib Sodium for Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20193152 | 2020/12/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Parecoxib Sodium for Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20193153 | 2020/12/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Clopidogrel Hydrogen Sulphate Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203701 | 2020/12/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Memantine Hydrochloride Sustained-release Capsules | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203560 | 2020/11/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Capecitabine Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203570 | 2020/11/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Memantine Hydrochloride Sustained-release Capsules | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203561 | 2020/11/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Glycopyrrolate Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203546 | 2020/11/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Glycopyrrolate Injection | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203545 | 2020/11/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olanzapine Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20203131 | 2020/03/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bisoprolol Fumarate Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20083007 | 2020/01/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Etoricoxib Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20193302 | 2019/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20193304 | 2019/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20193303 | 2019/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mirogabalin Besilate Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20264689 | 2026/06/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mirogabalin Besilate Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20264690 | 2026/06/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Apalutamide Tablets | Chengdu Easton Biopharmaceuticals Co.,Ltd. | Chengdu Easton Biopharmaceuticals Co.,Ltd. | 国药准字H20254353 | 2025/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
28 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Ibuprofen Injection | CYHB2601736 | Supplement | 2026/09/15 | Guangxi Ming Lei Wei Sheng Pharmaceutical Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Compound Glycyrrhizin Tablets | CYHB2601315 | Supplement | 2026/07/10 | Ji Ning Shen Zhou Pharmaceuticals Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Mirogabalin Besilate Tablets | CYHB2601290 | Supplement | 2026/07/08 | Chengdu Shuo De Pharma Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Mirogabalin Besilate Tablets | CYHB2601289 | Supplement | 2026/07/08 | Chengdu Shuo De Pharma Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Mirogabalin Besilate Tablets | CYHB2601288 | Supplement | 2026/07/08 | Chengdu Shuo De Pharma Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | JTH2500204 | Not stated by source | 2025/12/29 | UNITED STATES PHARMACOPEIAL CONVENTION; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | JTH2500018 | Not stated by source | 2025/02/26 | EDQM; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | JTH2500017 | Not stated by source | 2025/02/26 | UNITED STATES PHARMACOPEIAL CONVENTION; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Norepinephrine Bitartrate Injection | CYHB2402183 | Supplement | 2024/12/21 | Chengdu Shuo De Pharma Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Norepinephrine Bitartrate Injection | CYHB2402182 | Supplement | 2024/12/21 | Chengdu Shuo De Pharma Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | JTH2400160 | Not stated by source | 2024/09/11 | UNITED STATES PHARMACOPEIAL CONVENTION; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | JTH2400154 | Not stated by source | 2024/08/28 | EDQM; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | CYHB2400888 | Supplement | 2024/06/26 | Beijing Xin Nuo Kang Qiao Drug Research Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | CYHB2400886 | Supplement | 2024/06/26 | Beijing Xin Nuo Kang Qiao Drug Research Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Arotinolol Hydrochloride Tablets | CYHB2400501 | Supplement | 2024/04/16 | Beijing Xin Nuo Kang Qiao Drug Research Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Esomeprazole Magnesium for Delayed-release Oral Suspension | CYHB2302461 | Supplement | 2023/11/10 | Beijing Foyou Pharma CO.,LTD; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Esomeprazole Magnesium for Delayed-release Oral Suspension | CYHB2302460 | Supplement | 2023/11/10 | Beijing Foyou Pharma CO.,LTD; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Esomeprazole Magnesium for Delayed-release Oral Suspension | CYHB2302220 | Supplement | 2023/10/09 | Beijing Foyou Pharma CO.,LTD; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Esomeprazole Magnesium for Delayed-release Oral Suspension | CYHB2302219 | Supplement | 2023/10/09 | Beijing Foyou Pharma CO.,LTD; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Ibuprofen Injection | CYHB2301462 | Supplement | 2023/07/02 | Chengdu Shuo De Pharma Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Vigabatrin Powder for Oral Solution | CYHB2301131 | Supplement | 2023/05/19 | Ling Yao Bio Technology (Shanghai) Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | CYHB2300902 | Supplement | 2023/04/27 | Zhejiang Tai Li Sen Pharma Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | JTH2300004 | Not stated by source | 2023/01/08 | EDQM; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | JTH2200171 | Not stated by source | 2022/09/01 | UNITED STATES PHARMACOPEIAL CONVENTION; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | JTH2200170 | Not stated by source | 2022/09/01 | UNITED STATES PHARMACOPEIAL CONVENTION; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| No verified English name | JTH2200168 | Not stated by source | 2022/08/30 | UNITED STATES PHARMACOPEIAL CONVENTION; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Sodium Ibandronate Injection | CYHB2200686 | Supplement | 2022/04/25 | Chengdu Guo Wei Biopharmaceuticals Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| Paricalcitol Injection | CYHB2200685 | Supplement | 2022/04/25 | Chengdu Guo Wei Biopharmaceuticals Co., Ltd. romanized; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.